NCT06506019View on ClinicalTrials.gov

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

January 1, 2027

Conditions
Bipolar Depression
Interventions
DRUG

Psilocybin

25 mg psilocybin

DEVICE

Functional MRI

The fMRI involving resting state measures and a facial affect task will be conducted one-day and one-month after the dosing session.

Trial Locations (1)

M5T 2S8

RECRUITING

Toronto Western Hospital - University Health Network, Toronto

All Listed Sponsors
collaborator

Centre for Addiction and Mental Health

OTHER

lead

University Health Network, Toronto

OTHER